The first malaria vaccine RTS,S, will initially be rolled out on a pilot basis, given its limited efficacy, World Health Organisation advisory group has recommended.
The WHO's Strategic Advisory Group of Experts on Immunisation (Sage) and the Malaria Policy Advisory Committee (MPAC) jointly recommended that the pilot projects help understand how best to deliver the vaccine, also known as Mosquirix.
The decision is likely to delay a possible broad roll-out of the vaccine for between three and five years. It was expected that the vaccine would be recommended for use by 2017.
"The question about how the malaria vaccine can best be delivered still needs to be answered," said Jon Abramson, chair of Sage. "After detailed assessment of all the evidence, we recommended that this question is best addressed by having 3-5 large pilot implementation projects."
Read the full article here